A Study Evaluating the Effect of Filgotinib Dose De-escalation in Participants With Ulcerative Colitis (UC) in Remission
Clinical trial NCT05479058 · TERMINATED
Trial details
- NCT number
- NCT05479058
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-26
- Primary completion
- 2023-10-09
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.